Genotypic Assay - TB Second Line Drug

This test detects resistance to second-line drugs used to treat multidrug-resistant tuberculosis (MDR-TB). It is essential for tailoring effective treatment regimens for TB patients.

Also known asTb Second Line Drug Resistance (lpa) Tb Second Line Drug Resistance (lpa)

Available via

Home Collection, Lab Visit

Contains

4 parameters

Earliest reports in

3 Working Days

Test details

Genotypic Assay - TB Second Line Drug Test in Bengaluru Overview

Preparations

No special preparations needed

Test included
Genotypic Assay - TB Second Line Drug includes 4 parameters

  • Mycobacterium Tuberculosis Complex
  • Fluoroquinolone Resistance
  • Aminoglycosides/cyclic Peptides Resistance
  • Low Level Kanamycin Resistance
Frequently Asked Questions

This test detects resistance to second-line tuberculosis drugs in patients with multidrug-resistant TB (MDR-TB).

  • Patients with MDR-TB.

Individuals not responding to TB treatment.

A sputum sample is analyzed using molecular assays or culture-based drug susceptibility testing.

  • Resistance detected: Adjust treatment accordingly.

No resistance detected: Current treatment remains effective.

It ensures effective TB treatment and prevents further drug resistance.

Test code

9957

Specimen vol. and vacutainer information
SpecimenVacutainerVolume
BalPlain Sterile Vaccutainer 3 ML
CultureOthers3 ML
SputumPlain Sterile Vaccutainer 3 ML

Specimen stability information

Bal, Culture, Sputum

Collection instructions

Age,Gender,Clinical history required

Specimen rejection criteria

Test run frequency

Monday,Thursday TIME - 10:00

Turn around time

3 Working Days

Performing locations

Department

  • Molecular Biology

CPT and Loinc codes

Genotypic Assay - TB Second Line Drug

6500